Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | Patent Number 10266594
US 10266594 B1Filled DateDec 7, 2018
Priority DateMay 15, 2012
Publication DateApr 4, 2019
Expiration DateMay 14, 2032
Inventor/ApplicantsXi-Tao Wang
Stacie M. Goldberg
Maria Jure-Kunkel
John P. Cogswell
Jon M. Wigginton
Ashok K. Gupta
Stacie M. Goldberg
Maria Jure-Kunkel
John P. Cogswell
Jon M. Wigginton
Ashok K. Gupta
ExaminesOUSPENSKI, ILIA I
Art Unit1644
Technology Center1600
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.